CSF3 and Miyoshi myopathy: The largest previous RCT comparing plerixafor + G-CSF with placebo + G-CSF in patients with MM was published in 2009, with a median patient age of 58 years and only 5.9% of patients receiving lenalidomide before HSPC mobilization.